B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

RAB7A

MOLECULAR TARGET

RAB7A, member RAS oncogene family

UniProt: P51149NCBI Gene: 78792 compounds

RAB7A (RAB7A, member RAS oncogene family) is targeted by 2 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting RAB7A

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1Guanosine Diphosphate1.795
2Guanosine Triphosphate Guanosine 5'-(tetrahydrogen triphosphate).1.795

About RAB7A as a Drug Target

RAB7A (RAB7A, member RAS oncogene family) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 2 compounds with documented RAB7A interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

RAB7A inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.